LorenSMichelMDMD

Head & Neck Cancer

Associate Member, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center

Overview of Dr. Michel

Dr. Loren Michel is an oncologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Hackensack Meridian Health Riverview Medical Center, and Overlook Medical Center. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 29 years. Dr. Michel accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at Hackensack Meridian Health Riverview Medical Center who specialize in Oncology. He also speaks multiple languages, including Spanish. He has more than 40 publications and over 500 citings.

Office
136 Mountain View Boulevard
Basking Ridge, NJ 07920
Book by Phone+1(708) 546-4394

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 2000
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1994 - 1996
Cleveland Clinic FoundationInternship, Internal Medicine, 1988 - 1989
Case Western Reserve University School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 2021 - Present
CO State Medical License 2022 - 2025
NJ State Medical License 2016 - 2025
NY State Medical License 1994 - 2025
PA State Medical License 2023 - 2024
MO State Medical License 2005 - 2017
OH State Medical License 1989 - 1996
TN State Medical License 1988 - 1992
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Start of enrollment: 2005 Sep 14
Recruiting
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07
Completed
Phase 1
Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
Terminated
Phase 3
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2013 May 31
Completed
Phase 1
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03
Terminated
Phase 1, Phase 2
PD 0332991 and Cetuximab in Patients With Incurable SCCHN Start of enrollment: 2014 Jun 17
Completed
Phase 1, Phase 2
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer Start of enrollment: 2018 Sep 07
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Sacituzumab Govitecan in Patients With Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results From the Phase 2 TROPiCS-03 Basket Study.
Loren Michel, Antonio Jimeno, Ammar Sukari, J Thaddeus Beck, Joanne Chiu
Clinical Cancer Research. 2024-12-12
1 citations
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer.
Antoine Desilets, David G Pfister, Sarah Stein, Winston Wong, Eric J Sherman
Oral Oncology. 2024-07-01
13 citations
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Nancy Y Lee, Eric J Sherman, HeiKo Schöder, Rick Wray, Jay O Boyle
Journal of Clinical Oncology. 2024-03-10

Grant Support

The Role Of Trop2 In Prostate Stem Cell Biology And TumorigenesisNational Cancer Institute2012
Role Of Notch-Egfr Pathway Cooperativity In Basal-Like Breast CancerNational Cancer Institute2011
Analysis Of Loss Of Function Of MAD2 In MammalsNational Center For Research Resources2006
Analysis Of Loss Of Function Of MAD2 In MammalsNational Cancer Institute2005–2006
Analysis Of Loss Of Function Of MAD2 In MammalsNational Cancer Institute2001–2004

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Spanish

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
Anthem HealthKeepers HMO/POS
Anthem KeyCare PPO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Texas BlueChoice
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment